International survey on the management of patients with SLE. III. The results of a questionnaire regarding renal involvement

A. Doria, C. Vltali, A. Tincani, G. Balestrieri, M. Galeazzi, P. L. Meroni, P. Migliorini, R. Neri, A. Tavoni, S. Bombardieri

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective. To assess the practice patterns in the management of lupus nephritis (LN) of physicians dealing with systemic lupus erythematosus. Methods. A multiple choice questionnaire was sent to 135 lupus centers, mainly in Europe. It was divided into 4 sections, one of which regarded LN. Sixty-one centers (40%) sent the questionnaire back before the meeting; however, two of them did not fill out the LN section. Therefore, 59 valid LN questionnaires were collected and analyzed. Statistical evaluation was performed using frequency analysis and the chi-square test. Results. In 50 centers (85%), renal biopsy is performed in all patients with clinically evident renal involvement, and in most of them it is repeated in cases of relapse and/or ineffectiveness of treatment. Oral steroid alone is the therapy preferred by 67% of responding physicians in patients with WHO class II LN. Multi-drug therapy is favoured by 57% in patients with class III LN, by 79% for mild-to-moderate forms of class IV LN (IVm), by 84% for moderate-to-severe forms of class IV LN (IVs), by 47% for mild-to-moderate forms of class V LN (Vm), and by 65% for moderate-to-severe forms of class V LN (Vs). Steroids plus cyclophosphamide (CYPH) is the association most commonly used for class III, IVm and IVs LN, having been indicated by 70%, 80% and 88% of the centers, respectively. Furthermore, pulse CYPH is largely preferred to oral CYPH by the majority of centers. It is worth noting that 41 centers (70%, p <0.01) utilise the same drugs in the treatment of both WHO class IVm and IVs LN. No clear trends in the use of multi-drug associations were identifiable in the treatment of class V LN. Moreover, most of the centers (64%) said that they rely on histologic parameters in order to define renal prognosis and that they consider the chronicity index to be the best predictor of poor renal outcome (74% of the centers). Conclusions. It was possible to identify some clear trends in the behaviour of physicians who are 'expert' in lupus patients: (i) they perform a renal biopsy in order to charaterize the LN and repeat it when they are faced with relapse or ineffective therapy; (ii) they treat WHO class II LN with oral steroids alone and class III and IV LN with steroids associated with CYPH (CYPH, generally in a pulse regimen); and (iii) they define renal prognosis by means of histologic predictors, especially the chronicity index. However, no trend seemed to exist for the treatment of class V LN, particularly Vm.

Original languageEnglish
JournalClinical and Experimental Rheumatology
Volume14
Issue numberSUPPL. 16
Publication statusPublished - Nov 1996

Fingerprint

Lupus Nephritis
Kidney
Cyclophosphamide
Steroids
Surveys and Questionnaires
Physicians
Therapeutics
Biopsy
Recurrence
Chi-Square Distribution

Keywords

  • prognosis
  • renal biopsy
  • renal involvement
  • SLE
  • therapy

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

International survey on the management of patients with SLE. III. The results of a questionnaire regarding renal involvement. / Doria, A.; Vltali, C.; Tincani, A.; Balestrieri, G.; Galeazzi, M.; Meroni, P. L.; Migliorini, P.; Neri, R.; Tavoni, A.; Bombardieri, S.

In: Clinical and Experimental Rheumatology, Vol. 14, No. SUPPL. 16, 11.1996.

Research output: Contribution to journalArticle

Doria, A, Vltali, C, Tincani, A, Balestrieri, G, Galeazzi, M, Meroni, PL, Migliorini, P, Neri, R, Tavoni, A & Bombardieri, S 1996, 'International survey on the management of patients with SLE. III. The results of a questionnaire regarding renal involvement', Clinical and Experimental Rheumatology, vol. 14, no. SUPPL. 16.
Doria, A. ; Vltali, C. ; Tincani, A. ; Balestrieri, G. ; Galeazzi, M. ; Meroni, P. L. ; Migliorini, P. ; Neri, R. ; Tavoni, A. ; Bombardieri, S. / International survey on the management of patients with SLE. III. The results of a questionnaire regarding renal involvement. In: Clinical and Experimental Rheumatology. 1996 ; Vol. 14, No. SUPPL. 16.
@article{3e0a1532c7d84b3789fa457c115bae62,
title = "International survey on the management of patients with SLE. III. The results of a questionnaire regarding renal involvement",
abstract = "Objective. To assess the practice patterns in the management of lupus nephritis (LN) of physicians dealing with systemic lupus erythematosus. Methods. A multiple choice questionnaire was sent to 135 lupus centers, mainly in Europe. It was divided into 4 sections, one of which regarded LN. Sixty-one centers (40{\%}) sent the questionnaire back before the meeting; however, two of them did not fill out the LN section. Therefore, 59 valid LN questionnaires were collected and analyzed. Statistical evaluation was performed using frequency analysis and the chi-square test. Results. In 50 centers (85{\%}), renal biopsy is performed in all patients with clinically evident renal involvement, and in most of them it is repeated in cases of relapse and/or ineffectiveness of treatment. Oral steroid alone is the therapy preferred by 67{\%} of responding physicians in patients with WHO class II LN. Multi-drug therapy is favoured by 57{\%} in patients with class III LN, by 79{\%} for mild-to-moderate forms of class IV LN (IVm), by 84{\%} for moderate-to-severe forms of class IV LN (IVs), by 47{\%} for mild-to-moderate forms of class V LN (Vm), and by 65{\%} for moderate-to-severe forms of class V LN (Vs). Steroids plus cyclophosphamide (CYPH) is the association most commonly used for class III, IVm and IVs LN, having been indicated by 70{\%}, 80{\%} and 88{\%} of the centers, respectively. Furthermore, pulse CYPH is largely preferred to oral CYPH by the majority of centers. It is worth noting that 41 centers (70{\%}, p <0.01) utilise the same drugs in the treatment of both WHO class IVm and IVs LN. No clear trends in the use of multi-drug associations were identifiable in the treatment of class V LN. Moreover, most of the centers (64{\%}) said that they rely on histologic parameters in order to define renal prognosis and that they consider the chronicity index to be the best predictor of poor renal outcome (74{\%} of the centers). Conclusions. It was possible to identify some clear trends in the behaviour of physicians who are 'expert' in lupus patients: (i) they perform a renal biopsy in order to charaterize the LN and repeat it when they are faced with relapse or ineffective therapy; (ii) they treat WHO class II LN with oral steroids alone and class III and IV LN with steroids associated with CYPH (CYPH, generally in a pulse regimen); and (iii) they define renal prognosis by means of histologic predictors, especially the chronicity index. However, no trend seemed to exist for the treatment of class V LN, particularly Vm.",
keywords = "prognosis, renal biopsy, renal involvement, SLE, therapy",
author = "A. Doria and C. Vltali and A. Tincani and G. Balestrieri and M. Galeazzi and Meroni, {P. L.} and P. Migliorini and R. Neri and A. Tavoni and S. Bombardieri",
year = "1996",
month = "11",
language = "English",
volume = "14",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "SUPPL. 16",

}

TY - JOUR

T1 - International survey on the management of patients with SLE. III. The results of a questionnaire regarding renal involvement

AU - Doria, A.

AU - Vltali, C.

AU - Tincani, A.

AU - Balestrieri, G.

AU - Galeazzi, M.

AU - Meroni, P. L.

AU - Migliorini, P.

AU - Neri, R.

AU - Tavoni, A.

AU - Bombardieri, S.

PY - 1996/11

Y1 - 1996/11

N2 - Objective. To assess the practice patterns in the management of lupus nephritis (LN) of physicians dealing with systemic lupus erythematosus. Methods. A multiple choice questionnaire was sent to 135 lupus centers, mainly in Europe. It was divided into 4 sections, one of which regarded LN. Sixty-one centers (40%) sent the questionnaire back before the meeting; however, two of them did not fill out the LN section. Therefore, 59 valid LN questionnaires were collected and analyzed. Statistical evaluation was performed using frequency analysis and the chi-square test. Results. In 50 centers (85%), renal biopsy is performed in all patients with clinically evident renal involvement, and in most of them it is repeated in cases of relapse and/or ineffectiveness of treatment. Oral steroid alone is the therapy preferred by 67% of responding physicians in patients with WHO class II LN. Multi-drug therapy is favoured by 57% in patients with class III LN, by 79% for mild-to-moderate forms of class IV LN (IVm), by 84% for moderate-to-severe forms of class IV LN (IVs), by 47% for mild-to-moderate forms of class V LN (Vm), and by 65% for moderate-to-severe forms of class V LN (Vs). Steroids plus cyclophosphamide (CYPH) is the association most commonly used for class III, IVm and IVs LN, having been indicated by 70%, 80% and 88% of the centers, respectively. Furthermore, pulse CYPH is largely preferred to oral CYPH by the majority of centers. It is worth noting that 41 centers (70%, p <0.01) utilise the same drugs in the treatment of both WHO class IVm and IVs LN. No clear trends in the use of multi-drug associations were identifiable in the treatment of class V LN. Moreover, most of the centers (64%) said that they rely on histologic parameters in order to define renal prognosis and that they consider the chronicity index to be the best predictor of poor renal outcome (74% of the centers). Conclusions. It was possible to identify some clear trends in the behaviour of physicians who are 'expert' in lupus patients: (i) they perform a renal biopsy in order to charaterize the LN and repeat it when they are faced with relapse or ineffective therapy; (ii) they treat WHO class II LN with oral steroids alone and class III and IV LN with steroids associated with CYPH (CYPH, generally in a pulse regimen); and (iii) they define renal prognosis by means of histologic predictors, especially the chronicity index. However, no trend seemed to exist for the treatment of class V LN, particularly Vm.

AB - Objective. To assess the practice patterns in the management of lupus nephritis (LN) of physicians dealing with systemic lupus erythematosus. Methods. A multiple choice questionnaire was sent to 135 lupus centers, mainly in Europe. It was divided into 4 sections, one of which regarded LN. Sixty-one centers (40%) sent the questionnaire back before the meeting; however, two of them did not fill out the LN section. Therefore, 59 valid LN questionnaires were collected and analyzed. Statistical evaluation was performed using frequency analysis and the chi-square test. Results. In 50 centers (85%), renal biopsy is performed in all patients with clinically evident renal involvement, and in most of them it is repeated in cases of relapse and/or ineffectiveness of treatment. Oral steroid alone is the therapy preferred by 67% of responding physicians in patients with WHO class II LN. Multi-drug therapy is favoured by 57% in patients with class III LN, by 79% for mild-to-moderate forms of class IV LN (IVm), by 84% for moderate-to-severe forms of class IV LN (IVs), by 47% for mild-to-moderate forms of class V LN (Vm), and by 65% for moderate-to-severe forms of class V LN (Vs). Steroids plus cyclophosphamide (CYPH) is the association most commonly used for class III, IVm and IVs LN, having been indicated by 70%, 80% and 88% of the centers, respectively. Furthermore, pulse CYPH is largely preferred to oral CYPH by the majority of centers. It is worth noting that 41 centers (70%, p <0.01) utilise the same drugs in the treatment of both WHO class IVm and IVs LN. No clear trends in the use of multi-drug associations were identifiable in the treatment of class V LN. Moreover, most of the centers (64%) said that they rely on histologic parameters in order to define renal prognosis and that they consider the chronicity index to be the best predictor of poor renal outcome (74% of the centers). Conclusions. It was possible to identify some clear trends in the behaviour of physicians who are 'expert' in lupus patients: (i) they perform a renal biopsy in order to charaterize the LN and repeat it when they are faced with relapse or ineffective therapy; (ii) they treat WHO class II LN with oral steroids alone and class III and IV LN with steroids associated with CYPH (CYPH, generally in a pulse regimen); and (iii) they define renal prognosis by means of histologic predictors, especially the chronicity index. However, no trend seemed to exist for the treatment of class V LN, particularly Vm.

KW - prognosis

KW - renal biopsy

KW - renal involvement

KW - SLE

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=12644296017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12644296017&partnerID=8YFLogxK

M3 - Article

C2 - 9049451

AN - SCOPUS:12644296017

VL - 14

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - SUPPL. 16

ER -